OTCMKTS:CVSI CV Sciences (CVSI) Stock Price, News & Analysis $0.01 0.00 (0.00%) As of 10/21/2026 03:37 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartNews and TrendsSEC Filings About CV Sciences Stock (OTCMKTS:CVSI) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get CV Sciences alerts:Sign Up Key Stats Today's Range$0.0092▼$0.012050-Day Range$0.01▼$0.0352-Week Range$0.01▼$0.10Volume383,551 shsAverage Volume403,226 shsMarket Capitalization$2.36 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview CV Sciences, Inc. is a life sciences company focused on hemp-derived cannabidiol (CBD) consumer products. The company develops, manufactures, and markets products under its PlusCBD brand, including CBD oils, softgels, gummies, capsules, topicals, and products formulated for pets. PlusCBD products are positioned for use in areas such as general wellness, relaxation, sleep, and recovery. CV Sciences distributes its products through e-commerce channels and a network of retail outlets, primarily in the United States, subject to applicable regulations governing hemp-derived products and dietary supplements. Founded in 2012, CV Sciences has historically focused on cannabinoid-based consumer health products and related research. The company has been led by Joseph Dowling, who has served as its chief executive officer. Its shares trade on the over-the-counter market under the symbol CVSI.AI Generated. May Contain Errors. Read More Receive CVSI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CV Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CVSI Stock News HeadlinesCV Sciences, Inc. (OTCMKTS:CVSI) Sees Significant Increase in Short InterestOctober 13, 2026 | americanbankingnews.comCV Sciences Welcomes Enactment of Federal Legislation Providing Additional Time for a Responsible, Science-Based Hemp Regulatory FrameworkSeptember 8, 2026 | theglobeandmail.comTrump’s Plan To Cheat HistoryChina has slashed its U.S. Treasury holdings by more than 45% from their peak, while building gold vaults and payment networks that bypass the dollar entirely. Since the Federal Reserve opened in 1913, the dollar has lost most of its purchasing power. Porter Stansberry argues a new monetary order is forming around AI infrastructure, chips and energy, pointing to stocks like Vertiv, GE Vernova and Arista Networks that have surged hundreds of percent in recent years. | Porter & Company (Ad)CV Sciences, Inc. (CVSI) Q2 2026 Earnings Call TranscriptAugust 13, 2026 | seekingalpha.comCV Sciences, Inc.: CV Sciences Launches PlusHLTH.com, Expanding Its Consumer Platform Beyond CannabinoidsAugust 12, 2026 | finanznachrichten.deCV Sciences Shareholders Elect Directors, Reject Reverse Stock SplitJune 4, 2026 | tipranks.comCV Sciences, Inc. (CVSI) Shareholder/Analyst Call Prepared Remarks TranscriptJune 2, 2026 | seekingalpha.comCV Sciences Inc (CVSI) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strategic ...May 15, 2026 | finance.yahoo.comSee More Headlines CVSI Stock Analysis - Frequently Asked Questions How have CVSI shares performed this year? CV Sciences' stock was trading at $0.0614 at the beginning of the year. Since then, CVSI stock has decreased by 83.7% and is now trading at $0.01. How were CV Sciences' earnings last quarter? CV Sciences, Inc. (OTCMKTS:CVSI) released its earnings results on Thursday, August, 12th. The company reported ($0.03) EPS for the quarter, meeting the consensus estimate of ($0.03). The business had revenue of $5.13 million for the quarter, compared to the consensus estimate of $5.12 million. CV Sciences had a negative net margin of 15.74% and a negative trailing twelve-month return on equity of 132.06%. How do I buy shares of CV Sciences? Shares of CVSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of CV Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that CV Sciences investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Cronos Group (CRON), Charlotte's Web (CWBHF), Organigram Global (OGI), Kushco (KSHB) and Medical Marijuana (MJNA). Company Calendar Last Earnings8/12/2021Today10/22/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:CVSI Previous SymbolNASDAQ:CVSI CIK1510964 Webwww.cvsciences.com Phone(866) 290-2157Fax619-876-4321Employees43Year Founded2016Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$960 thousand Net Margins-15.74% Pretax Margin-15.69% Return on Equity-132.06% Return on Assets-29.50% Debt Debt-to-Equity RatioN/A Current Ratio0.99 Quick Ratio0.18 Sales & Book Value Annual Sales$13.79 million Price / Sales0.17 Cash FlowN/A Price / Cash FlowN/A Book Value$0.01 per share Price / Book1.00Miscellaneous Outstanding Shares235,690,000Free Float219,903,000Market Cap$2.36 million OptionableNot Optionable Beta0.43 Social Links Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven.Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free Report This page (OTCMKTS:CVSI) was last updated on 10/21/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | Sponsored80 Days Until the Pentagon Restricts Chinese Rare EarthsChina controls more than 90% of global rare earth alloy production, leverage it is using to restrict exports t...The Tomorrow Investor | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredDon't lose access to thisIan Cooper is giving away his guide, The Simple Path To Success With Options, before it moves behind a paywall...TradeWins | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CV Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CV Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
